Press Release: MVision AI is selected to provide its Contour+ solution by the Republic of Ireland’s Health Service Executive (HSE) for its first installation in the country

HELSINKI, Finland – September 14, 2023

MVision AI is experiencing ongoing and rapid growth within the health service sector globally. The company is delighted to announce that we have successfully been awarded the tender from the Republic of Ireland’s Health Service Executive (HSE) for the installation of our Contour+ auto contouring solution at Cork University Hospital.

“MVision AI are truly delighted to have been selected as the preferred supplier of an AI auto contouring system to Cork University Hospital. This will be the first deployment of our Guideline Based Contour+ solution via our Cloud service within this country,” says Stewart Pegrum, MVision AI’s Vice President of Global Sales.

The procurement was undertaken via a national EU tender process, which was published on 3rd February 2023 Each tender applicant was evaluated on Qualitative Selection Criteria including; Economic and Financial Standing, Technical and Professional Ability and Quality Assurance Standards.

Tenders that achieve the minimum requirements set out in the Qualitative Selection Criteria were then evaluated to determine which presented the most economically advantageous tender using the award criteria below:

Project Management & Installation (5%)

Primary Requirements (5%)

Functional Requirements (10%)

Clinical Requirements (25%)

ICT Technical Requirements (10%)

Service & Support (5%)

Training & Documentation (5%)

Sustainability (5%)

Cost (30%)

As part of the clinical requirements sample delineations for a selection of structures were requested for evaluation purposes from the Tenderers. These were reviewed by the tender panel that was made up of Medical Physicists, Radiation Oncologists, Radiation therapists and HSE procurement representatives.

We recently started SABR Lung treatments and expect to introduce SABR Liver and SRS treatments in the near future. We hope MVision AI will help us to standardize contouring in line with best practice guidelines and reduce the time spent delineating patient datasets by approximately 50%,” says Mr. Michael Roche, Principal Physicist, Medical Physics Department in Cork University Hospital. 

MVision AI’s interests in the UK and Ireland are represented by our longstanding distributor, Xiel, which specializes in providing solutions for Nuclear Medicine, Radiotherapy, and Diagnostic Radiology.

“We are delighted that CUH have selected MVision AI as their solution for auto contouring, this was a very stringent process with much interaction and this award demonstrates the robust capabilities of Contour +”, says Phil Neale, Xiel’s Key Account Consultant in Radiotherapy Physics.

About MVision AI

MVision AI is an innovative software service provider for radiotherapy treatment planning. Our AI-powered automatic segmentation tool, Contour+, helps to standardize contouring and automate segmentation to streamline the radiotherapy treatment planning workflow.

MVision.ai

MVision AI Linkedin page

MVision AI Media Kit

About Cork University Hospital (CUH)

Currently Cork University Hospital (CUH) treats c.2000 patients annually. At present, the majority of volume delineation is a time-consuming process and is manually performed by CUH’s 7 Consultant Radiation Oncologists  who may be assisted at times by other staff members including Dosimetrists or Radiation Therapists. A new radiotherapy facility was opened in 2019.
CUH.hse.ie

Cork University Hospitals Linkedin Group

About Xiel. 

Xiel is a specialist distributor of medical technologies in the UK and Ireland. We work with global leading solution providers; therefore, continuously improving efficiency and quality for our customers. Our partners research and develop highly specific products for what is often a small world market. The expertise of Xiel lies in our deep understanding of the structure and organisation of radiotherapy departments in the UK and Ireland, for us to advise on the best solutions possible. Xiel. Exceptional Products. Extraordinary Service. Everyday.

Xiel.co.uk

Xiel Linkedin page

 

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

14.6.2024

MVision AI Appoints Antti Pirskanen as New Chief Financial Officer

Helsinki, Finland – June 14, 2024 – MVision AI, a pioneering company in the development of innovative AI solutions for radiation oncology is pleased to announce the appointment of Antti Pirskanen as its new Chief Financial Officer (CFO). Antti will assume his responsibilities immediately, bringing extensive expertise in financial management…

Press Releases

14.6.2024

MVision AI Receives MFDS Approval and Market Authorization for South Korea

HELSINKI, Finland – June 14, 2024 MVision AI is pleased to announce that our application for MVision AI Segmentation (Contour+) in South Korea has been accepted by the Ministry of Food and Drug Safety (MFDS) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation…

Press Releases

14.6.2024

From Awareness to Action: International Men’s Health Week and Cancer Screening

This year, from 10 to 16 June we celebrate the International Men's Health Week. The dates are different each year, so it precedes and includes Father's Day. Multiple activities around the world aim to raise awareness of men’s preventable health problems and early detection (1). The official framework was created…

Articles